Show & Exhibition Gateway 2012 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Show & Exhibition Gateway 2012
Your online Gateway to industry shows and expositions in 2012.


3M Drug Delivery Systems
View profile

Abbott Laboratories
View profile

AdvantaPure
View profile

Allegheny Bradford Corporation
View profile

AMRI
View profile

Aptalis Pharmaceutical Technologies
View profile

Baxter BioPharma Solutions
View profile

Brabender Pharma
View profile

Brookfield Engineering Laboratories
View profile

Cambridge Major Laboratories
View profile

Corden Pharma
View profile

Dwyer Instruments Inc.
View profile

Eurofins Lancaster Laboratories
View profile

Fluid Metering
View profile

FOSS NIRSystems, Inc
View profile

GE Analytical Instruments
View profile

Gemü Valves
View profile

Grand River Aseptic Manufacturing
View profile

Hamilton Company
View profile

Hospira One 2 One
View profile

I Holland Limited
View profile

International Centre for Diffraction Data
View profile

Jost Chemical Co
View profile

Labconco Corporation
View profile

Magnetrol
View profile

Meissner Filtration Products
View profile

Metrics, Inc.
View profile

MPI Research
View profile

Natoli Engineering Company, Inc.
View profile

Perfex
View profile

Rommelag
View profile

Ropack Inc.
View profile

Sartorius Stedim Biotech
View profile

Schenck AccuRate
View profile

Sensient Pharmaceutical Coating Systems
View profile

Shimadzu Scientific Instruments
View profile

Stäubli
View profile

Swagelok Company
View profile

Veltek Associates
View profile

Vetter
View profile

WellSpring Pharmaceutical Canada Corp
View profile

W.S. Tyler
View profile

 

 

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
8%
All of the above.
46%
No government involvement in patient treatment or drug development.
7%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing

Click here